Literature DB >> 21071436

Activated inositol 1,4,5-trisphosphate receptors are modified by homogeneous Lys-48- and Lys-63-linked ubiquitin chains, but only Lys-48-linked chains are required for degradation.

Danielle A Sliter1, Mike Aguiar, Steven P Gygi, Richard J H Wojcikiewicz.   

Abstract

Inositol 1,4,5-trisphosphate (IP(3)) receptors (IP(3)Rs) are large, ubiquitously expressed, endoplasmic reticulum membrane proteins that form tetrameric IP(3) and Ca(2+)-gated Ca(2+) channels. Endogenous IP(3)Rs provide very appealing tools for studying the ubiquitin-proteasome pathway in intact mammalian cells because, upon activation, they are rapidly ubiquitinated and degraded. Using mass spectrometry, we previously examined the ubiquitination of IP(3)R1 in αT3-1 pituitary gonadotrophs and found that IP(3)R1 ubiquitination is highly complex, with receptors being modified at multiple sites by monoubiquitin and polyubiquitin chains formed through both Lys-48 and Lys-63 linkages (Sliter, D. A., Kubota, K., Kirkpatrick, D. S., Alzayady, K. J., Gygi, S. P., and Wojcikiewicz, R. J. H. (2008) J. Biol. Chem. 283, 35319-35328). Here, we have extended these studies to determine whether IP(3)R2 and IP(3)R3 are similarly modified and if ubiquitination is cell type-dependent. Using mass spectrometry and linkage-specific ubiquitin antibodies, we found that all IP(3)R types are subject to ubiquitination at approximately the same locations and that, independent of cell type, IP(3)Rs are modified by monoubiquitin and Lys-48- and Lys-63-linked ubiquitin chains, although in differing proportions. Remarkably, the attached Lys-48- and Lys-63-linked ubiquitin chains are homogeneous and are segregated to separate IP(3)R subunits, and Lys-48-linked ubiquitin chains, but not Lys-63-linked chains, are required for IP(3)R degradation. Together, these data provide unique insight into the complexities of ubiquitination of an endogenous ubiquitin-proteasome pathway substrate in unperturbed mammalian cells. Importantly, although Lys-48-linked ubiquitin chains appear to trigger proteasomal degradation, the presence of Lys-63-linked ubiquitin chains suggests that ubiquitination of IP(3)Rs may have physiological consequences beyond signaling for degradation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071436      PMCID: PMC3020714          DOI: 10.1074/jbc.M110.188383

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Down-regulation of types I, II and III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin/proteasome pathway.

Authors:  J Oberdorf; J M Webster; C C Zhu; S G Luo; R J Wojcikiewicz
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

2.  Secretagogues cause ubiquitination and down-regulation of inositol 1, 4,5-trisphosphate receptors in rat pancreatic acinar cells.

Authors:  R J Wojcikiewicz; S A Ernst; D I Yule
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

3.  Angiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells. Evidence for involvement of the proteasome pathway.

Authors:  S Bokkala; S K Joseph
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

Review 4.  Polyubiquitin chains: polymeric protein signals.

Authors:  Cecile M Pickart; David Fushman
Journal:  Curr Opin Chem Biol       Date:  2004-12       Impact factor: 8.822

5.  Trypsinized cerebellar inositol 1,4,5-trisphosphate receptor. Structural and functional coupling of cleaved ligand binding and channel domains.

Authors:  F Yoshikawa; H Iwasaki; T Michikawa; T Furuichi; K Mikoshiba
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

6.  Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types.

Authors:  R J Wojcikiewicz
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

7.  Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair.

Authors:  R M Hofmann; C M Pickart
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

8.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Honglin Zhou; Michael Eby; L Aravind; Somasekar Seshagiri; Ping Wu; Christian Wiesmann; Rohan Baker; David L Boone; Averil Ma; Eugene V Koonin; Vishva M Dixit
Journal:  Nature       Date:  2004-07-18       Impact factor: 49.962

9.  Inositol 1,4,5-trisphosphate receptor ubiquitination is mediated by mammalian Ubc7, a component of the endoplasmic reticulum-associated degradation pathway, and is inhibited by chelation of intracellular Zn2+.

Authors:  Jack M Webster; Swati Tiwari; Allan M Weissman; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2003-07-17       Impact factor: 5.157

10.  A proteomics approach to understanding protein ubiquitination.

Authors:  Junmin Peng; Daniel Schwartz; Joshua E Elias; Carson C Thoreen; Dongmei Cheng; Gerald Marsischky; Jeroen Roelofs; Daniel Finley; Steven P Gygi
Journal:  Nat Biotechnol       Date:  2003-07-20       Impact factor: 54.908

View more
  10 in total

Review 1.  Proteasome protease mediated regulation of cytokine induction and inflammation.

Authors:  Nilofer Qureshi; David C Morrison; Julia Reis
Journal:  Biochim Biophys Acta       Date:  2012-06-19

2.  RNF170 protein, an endoplasmic reticulum membrane ubiquitin ligase, mediates inositol 1,4,5-trisphosphate receptor ubiquitination and degradation.

Authors:  Justine P Lu; Yuan Wang; Danielle A Sliter; Margaret M P Pearce; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2011-05-24       Impact factor: 5.157

Review 3.  Proteomic identification of protein ubiquitination events.

Authors:  Guoqiang Xu; Samie R Jaffrey
Journal:  Biotechnol Genet Eng Rev       Date:  2013

Review 4.  Hepatic cytochrome P450 ubiquitination: conformational phosphodegrons for E2/E3 recognition?

Authors:  Maria Almira Correia; YongQiang Wang; Sung-Mi Kim; Shenheng Guan
Journal:  IUBMB Life       Date:  2014-02-03       Impact factor: 3.885

5.  Isoform-specific regulation of the inositol 1,4,5-trisphosphate receptor by O-linked glycosylation.

Authors:  Patricia Bimboese; Craig J Gibson; Stefan Schmidt; Wanqing Xiang; Barbara E Ehrlich
Journal:  J Biol Chem       Date:  2011-03-07       Impact factor: 5.157

6.  A Point Mutation in the Ubiquitin Ligase RNF170 That Causes Autosomal Dominant Sensory Ataxia Destabilizes the Protein and Impairs Inositol 1,4,5-Trisphosphate Receptor-mediated Ca2+ Signaling.

Authors:  Forrest A Wright; Justine P Lu; Danielle A Sliter; Nicolas Dupré; Guy A Rouleau; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2015-04-16       Impact factor: 5.157

Review 7.  Historical perspective and progress on protein ubiquitination at glutamatergic synapses.

Authors:  Angela M Mabb
Journal:  Neuropharmacology       Date:  2021-06-29       Impact factor: 5.273

8.  Regulation of behavioral circadian rhythms and clock protein PER1 by the deubiquitinating enzyme USP2.

Authors:  Yaoming Yang; David Duguay; Nathalie Bédard; Adeline Rachalski; Gerardo Baquiran; Chan Hyun Na; Jan Fahrenkrug; Kai-Florian Storch; Junmin Peng; Simon S Wing; Nicolas Cermakian
Journal:  Biol Open       Date:  2012-06-28       Impact factor: 2.422

Review 9.  Cleaning up in the endoplasmic reticulum: ubiquitin in charge.

Authors:  John C Christianson; Yihong Ye
Journal:  Nat Struct Mol Biol       Date:  2014-04       Impact factor: 18.361

10.  Downregulation of Siah1 promotes colorectal cancer cell proliferation and migration by regulating AKT and YAP ubiquitylation and proteasome degradation.

Authors:  Zhiyuan Xiao; Zhigang Wei; Danling Deng; Zhe Zheng; Yali Zhao; Shenglu Jiang; Dan Zhang; Ling-Jie Zhang; Mingmei Fan; Siqi Chen; ShuYang Wang; Yanqing Ding; Yaping Ye; Hongli Jiao
Journal:  Cancer Cell Int       Date:  2020-02-13       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.